Abstract
The incidence of obesity and overweight is increasing worldwide. Obesity predisposes to the development of co-morbidities such as diabetes mellitus, hypertension, cardiovascular disease and malignancy. This chapter will focus on identifying and diagnosing common medical problems that obese patients encounter with an overview of managing these conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization. Overweight and obesity. Fact sheet no. 311. WHO: Geneva; 2006.
National Institute for Clinical Excellence (NICE). Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006. http://www.nice.org.uk/guidance/CG43.
Wass J, Owen K. Oxford handbook of endocrinology and diabetes. 3rd ed. Oxford: Oxford University Press; 2014.
Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96(9):2643–51.
Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18(2):190–7.
Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Jerums G, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93:1834–40.
Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med. 2008;8:816–28.
Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33:1186–92.
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–9.
Du Plessis SS, Cabler S, McAlister DA, Sabanegh E, Agarwal A. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol. 2010;7(3):153–61.
Chitaley K, Kupelian V, Subak L, Wessells H. Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol. 2009;182(6 Suppl):S45–50.
Basu A, Ryder RE. New treatment options for erectile dysfunction in patients with diabetes mellitus. Drugs. 2004;64(23):2667–88.
Hering R, Taheri S. Obstructive sleep apnoea and diabetes – an emerging link. J Diab Nurs. 2011;15(2):46–8.
Scottish Intercollegiate/British Thoracic Society Guideline. Management of obstructive sleep apnoea/hypopnoea syndrome in adults. Guideline No 73. 2003. http://www.sign.ac.uk/guidelines/fulltext/73/index.html.
Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2011;183(3):292–8.
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–9.
Everson SA, Maty SC, Lynch JW, Kaplan GA. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res. 2002;53(4):891–5.
Brownell KD, Kramer FM. Behavioral management of obesity. Med Clin North Am. 1989;73(1):185–201.
Kim JH, Shim KW, Yoon YS, Lee SY, Kim SS, Oh SW. Cigarette smoking increases abdominal and visceral obesity but not overall fatness: an observational study. PLoS One. 2012;7(9):e45815.
Sucharda P. Smoking and obesity. Vnitr Lek. 2010;56(10):1053–7.
Silveira LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013;98(5):1781–8.
Home P, Mant J, Diaz J, Turner C, Guideline Development Group. Guidelines: management of type 2 diabetes: summary of updated NICE guidance. BMJ. 2008;336(7656):1306.
Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study. Diabetes Care. 1998;21(8):1288–94.
Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ. 2012;344:d7771.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–59.
NICE guidelines for Sleep Apnoea and CPAP use 2008 (UK). www.nice.org.uk/Guidance/TA139.
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Shonibare, T., Rodriguez-Farradas, A., Ramasamy, M., Rajeswaran, C. (2015). Medical Problems in Obesity. In: Ajjan, R., Orme, S. (eds) Endocrinology and Diabetes. Springer, London. https://doi.org/10.1007/978-1-4471-2789-5_23
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2789-5_23
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2788-8
Online ISBN: 978-1-4471-2789-5
eBook Packages: MedicineMedicine (R0)